Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Jackson

Showing results (51-60 of 182) with videos related to

Pageof 19
Sort By:
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Fractional Exhaled Nitric Oxide as a Novel Biomarker of Relapse in Eosinophilic Granulomatosis with PolyangiitisFrancesca Cefaloni, Anne-Catherine Maynard-Paquette, Ajerico Del Rosario, et al.
Allergy|May 1, 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumabCharles H R Francis, Andrew P Hearn, Sharenja Ratnakumar, et al.
The European Respiratory Journal|February 16, 2020
Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthmaGráinne d'Ancona, Joanne Kavanagh, Cris Roxas, et al.
Ebiomedicine|July 3, 2015
Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory SymptomsKatarzyna Niespodziana, Clarissa R Cabauatan, David J Jackson, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 11, 2021
Home-based Digital Assessments with Applied Sentiment & Emotion AI Capture Improved Quality-of-life in Asthma PatientsBo Zhang, Ruben Buendia, Nicholas Iannoti, et al.
The Journal of Allergy and Clinical Immunology|November 9, 2024
Booster vaccination normalizes postvaccination immunity in patients with severe asthmaHitasha Rupani, Rekha Chaudhuri, David J Jackson, et al.
Advances in Therapy|September 8, 2023
Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International StudyAshraf Alzaabi, John P Bell, Felicia Montero-Arias, et al.
Lancet (London, England)|December 10, 2023
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 studyDavid J Jackson, Liam G Heaney, Marc Humbert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 24, 2022
Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic UseDavid J Jackson, Hassan Burhan, Andrew Menzies-Gow, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2025
Consensus summary on the definition of asthma remissionRohit K Katial, Michael E Wechsler, Praveen Akuthota, et al.
Pageof 19

Showing results (51-60 of 182) with videos related to

Sort By:
Pageof 19
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Fractional Exhaled Nitric Oxide as a Novel Biomarker of Relapse in Eosinophilic Granulomatosis with PolyangiitisFrancesca Cefaloni, Anne-Catherine Maynard-Paquette, Ajerico Del Rosario, et al.
Allergy|May 1, 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumabCharles H R Francis, Andrew P Hearn, Sharenja Ratnakumar, et al.
The European Respiratory Journal|February 16, 2020
Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthmaGráinne d'Ancona, Joanne Kavanagh, Cris Roxas, et al.
Ebiomedicine|July 3, 2015
Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory SymptomsKatarzyna Niespodziana, Clarissa R Cabauatan, David J Jackson, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 11, 2021
Home-based Digital Assessments with Applied Sentiment & Emotion AI Capture Improved Quality-of-life in Asthma PatientsBo Zhang, Ruben Buendia, Nicholas Iannoti, et al.
The Journal of Allergy and Clinical Immunology|November 9, 2024
Booster vaccination normalizes postvaccination immunity in patients with severe asthmaHitasha Rupani, Rekha Chaudhuri, David J Jackson, et al.
Advances in Therapy|September 8, 2023
Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International StudyAshraf Alzaabi, John P Bell, Felicia Montero-Arias, et al.
Lancet (London, England)|December 10, 2023
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 studyDavid J Jackson, Liam G Heaney, Marc Humbert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 24, 2022
Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic UseDavid J Jackson, Hassan Burhan, Andrew Menzies-Gow, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2025
Consensus summary on the definition of asthma remissionRohit K Katial, Michael E Wechsler, Praveen Akuthota, et al.
Pageof 19